HCA Healthcare, Inc. (NYSE:HCA) Receives $359.89 Consensus Target Price from Analysts
HCA Healthcare, Inc. (NYSE:HCA – Get Free Report) has received a consensus recommendation of “Moderate Buy” from the twenty-one analysts that are covering the company, MarketBeat Ratings reports. Five analysts have rated the stock with a hold rating, fourteen have given a buy rating and two have issued a strong buy rating on the company. […]
2 Oct 03:46 · The Cerbat Gem